Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Manta Ray Ventures

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 55
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 35
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.35
Exits 1
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Software
  • Food and Beverage
  • Health Care
  • Information Technology
  • Education
Summary

The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the London.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Manta Ray Ventures, startups are often financed by Troy Capital Partners, Point Nine Capital, The Pritzker Organization. The meaningful sponsors for the fund in investment in the same round are Kulczyk Investments, Upfront Ventures, Social Starts. In the next rounds fund is usually obtained by Seedcamp, Prosus, Idinvest Partners.

The overall number of key employees were 1.

Among the most successful fund investment fields, there are Internet, Information Technology. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Booksy, Brainly, Toonstar The fund has no exact preference in a number of founders of portfolio startups. When startup sums 1 or 5+ of the founder, the probability for it to get the investment is little.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 7-12 deals per year. The real fund results show that this VC is 4 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2018.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Binhu Ketou China, Jiangsu, Wuxi Shi
Co-Bridge Capital Beijing, Beijing, China
Colam Impact -
Crux Capital California, Menlo Park, United States
Elah Fund Israel, Jerusalem, Jerusalem District
Lewis Trust Group England, London, United Kingdom
P.plus Belgium, Limburg, Limburg

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cuemath

E-Learning
EdTech
Education
STEM Education
$57M01 Jun 2022 Bengaluru, Karnataka, India

Nomagic

Artificial Intelligence
Cloud Infrastructure
Logistics
Robotics
$22M24 May 2022 Warsaw, Masovian Voivodeship, Poland

Better Dairy

AgTech
Food and Beverage
$22M28 Feb 2022 London, England, United Kingdom

Future Meat Technologies

Biotechnology
Food Processing
Manufacturing
Organic Food
$347M17 Dec 2021 Jerusalem, Jerusalem District, Israel

Brickwise

Financial Services
Property Management
Real Estate Investment
$3M02 Dec 2021 -

Peek

Internet
Marketplace
Mobile
SaaS
Tourism
Travel
$80M23 Nov 2021 San Francisco, California, United States

Bite Ninja

Restaurants
Staffing Agency
$4M04 Nov 2021 San Jose, California, United States

Supplant

Biotechnology
Food and Beverage
Health Care
$18M12 Oct 2021 Cambridge, England, United Kingdom

Bluu Bioscience

$8M25 Mar 2021 Berlin, Berlin, Germany
News
Ossium Health Raises $63M in Series B Funding

– Ossium Health is a therapeutics company that leverages stem cell science to improve treatment for patients with blood and immune diseases.
– The company raised $63m in Series B funding.
– The round was co-led by General Catalyst and Vivo Capital with participation from previous investors First Round Capital, Manta Ray Ventures, and XYZ Capital.
– The new investment will be used to develop stem cell therapies for patients with life-threatening blood and immune diseases.

HelloSelf Raises £5.5M in Series A Funding

– HelloSelf is a London, UK-based AI-powered digital therapy service.
– The company raised £5.5M in Series A funding.
– The round was led by OMERS Ventures, with participation from Manta Ray Ventures, Oxford Capital Partners, and 2EnablePartners. In conjunction with the funding, Harry Briggs, OMERS Ventures Managing Partner will join the board.
– The company intends to use the funds to grow its @Work service, increasing its clinical provision for employers of all sizes across the UK.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Manta Ray Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: